Structural Analysis of the Mechanism of Inhibition and Allosteric Activation of the Kinase Domain of HER2 Protein
Kathleen Aertgeerts(Fleet Science Center), Satoshi Sogabe(Takeda (Japan)), R.J. Skene(Takeda (United States)), Noriyuki Habuka, Tomoyasu Ishikawa(Takeda (Japan)), Bi‐Ching Sang(Takeda (United States)), Jason K. Yano(Fleet Science Center), Gyorgy Snell(VIR Biotechnology (United States)), Andy Jennings(Takeda (United States)), Hiroshi Miki(Takeda (Japan)), Yoshikazu Ohta(University of Miyazaki), Keiji Iwamoto(Takeda (Japan)), Toshimasa Tanaka(Takeda (Japan)), Hua Zou(Children's Hospital of Chongqing Medical University), Aki Hirokawa(Takeda (Japan))
Cited by 441
Related Papers
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
|Cell|2021|656
Discovery of Potent Antagonists of the Antiapoptotic Protein XIAP for the Treatment of Cancer
|Journal of Medicinal Chemistry|2004|364